Skip to content
Clinical Trials for Alzheimer's Disease

Wellington, Florida

Alzheimer's disease clinical trials in Wellington, FL

8 Alzheimer's disease studies are recruiting participants at sites in Wellington as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Wellington at a glance

  • 8 studies are recruiting at a site in Wellington.
  • By phase: Phase 1 (1), Phase 1/2 (1), Phase 2 (3), Phase 3 (3).
  • By sponsor: industry (7), university, hospital or other (1).
  • Most recent update to one of these records: November 16, 2026.

Studies recruiting in Wellington

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

    • Phase 3
    • Ages 50 to 90
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    Alzheimer?s Research and Treatment Center
    Registry record
    NCT07177352 · updated
  2. Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease

    • Phase 2
    • Ages 50 to 90
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    Alzheimer?s Research and Treatment Center
    Registry record
    NCT07781657 · updated
  3. A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease

    • Phase 2
    • Ages 55 to 85
    • All sexes
    Sponsor
    Sanofi
    Study site
    Alzheimer's Research and Treatment Center - Wellington- Site Number : 8400012
    Registry record
    NCT07688213 · updated
  4. A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

    • Phase 3
    • Ages 55 to 80
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    Alzheimer?s Research and Treatment Center
    Registry record
    NCT07717411 · updated
  5. A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

    • Phase 3
    • Ages 60 to 85
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    Alzheimer's Research and Treatment Center
    Registry record
    NCT06976203 · updated
  6. Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

    • Phase 2
    • Ages 55 to 80
    • All sexes
    Sponsor
    Lighthouse Pharmaceuticals, Inc.
    Study site
    Alzheimer's Research and Treatment Center - Wellington
    Registry record
    NCT06847321 · updated
  7. A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease

    • Phase 1/2
    • Ages 50 to 90
    • All sexes
    Sponsor
    AbbVie
    Study site
    Alzheimer's Research And Treatment Center - Wellington /ID# 277749
    Registry record
    NCT07599670 · updated
  8. AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)

    • Phase 1
    • Ages 65 to 80
    • All sexes
    Sponsor
    Institute for Molecular Medicine
    Study site
    Alzheimer's Research and Treatment Center (Wellington)
    Registry record
    NCT07158905 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Wellington, FL on ClinicalTrials.gov.

Ask about studies near Wellington

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Florida

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call